Table 3. Univariate and multivariate analysis for factors associated with overall survival.
Variable | N = 185 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
HR (95% CI) | p -Value | HR (95% CI) | p -Value | ||
Age (y) | |||||
<50 | 65 (35.1%) | 1.00 | 0.124 | – | – |
≥50 | 120 (64.9%) | 1.85 (0.85–4.03) | – | ||
pT stage | |||||
pT0 + pT1 + pT2 | 42 (22.7%) | 1.00 | 0.018 | 1.00 | 0.152 |
pT3 + pT4 | 143 (77.3%) | 3.53 (1.24–9.99) | 2.30 (0.74–7.18) | ||
pN stage | |||||
pN0 | 55 (29.7%) | 1.00 | 0.056 | 1.00 | 0.773 |
pN1 + pN2 + pN3 | 130 (70.3%) | 2.08 (0.98–4.42) | 1.13 (0.49–2.62) | ||
Grade of the tumor | |||||
Poorly differentiated | 111 (60.0%) | 2.17 (1.02–4.60) | 0.044 | 1.90 (0.86–4.18) | 0.111 |
Well/moderately differentiated | 74 (40.0%) | 1.00 | 1.00 | ||
Omental metastasis | |||||
Yes | 20 (10.8%) | 2.89 (1.26–6.65) | 0.012 | 1.90 (0.80–4.43) | 0.146 |
No | 165 (89.2%) | 1.00 | 1.00 | ||
Perioperative chemotherapy | |||||
Yes | 71 (38.4%) | 0.45 (0.22–0.92) | 0.030 | 0.47 (0.22–0.98) | 0.046 |
No | 114 (61.6%) | 1.00 | 1.00 |
Note: Values expressed as n (%).